Ad is loading...
MENU

PCRX Pacira BioSciences Forecast, Technical & Fundamental Analysis

a manufacturer of injectable therapeutic products

PCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
PCRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

PCRX is expected to report earnings to 78 cents per share on February 27

Pacira BioSciences PCRX Stock Earnings Reports
Q4'24
Est.
$0.78
Q3'24
Beat
by $0.09
Q2'24
Beat
by $0.20
Q1'24
Est.
$0.62
Q4'23
Beat
by $0.01
The last earnings report on November 06 showed earnings per share of 79 cents, beating the estimate of 70 cents. With 115.43K shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

a manufacturer of injectable therapeutic products

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
5401 West Kennedy Boulevard
Phone
+1 813 553-6680
Employees
713
Web
https://www.pacira.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRNEX42.260.22
+0.52%
T. Rowe Price New Era I
OBEGX30.390.07
+0.23%
Oberweis Global Opportunities Investor
OAKIX25.47N/A
N/A
Oakmark International Investor
AUUIX23.63-0.02
-0.08%
AB Select US Equity I
WPSIX60.02-0.10
-0.17%
AB Concentrated Growth I

PCRX and Stocks

Correlation & Price change

A.I.dvisor tells us that PCRX and ELAN have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that PCRX and ELAN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCRX
1D Price
Change %
PCRX100%
+1.79%
ELAN - PCRX
32%
Poorly correlated
+0.98%
TEVA - PCRX
28%
Poorly correlated
+1.31%
BMCS - PCRX
27%
Poorly correlated
+2.70%
ACET - PCRX
27%
Poorly correlated
-6.11%
SNDL - PCRX
26%
Poorly correlated
-1.01%
More